Opharmic selected as the Winner of the 2021 APAC MedTech Innovator Competition
The Opharmic team are so thrilled to announce that amongst the top 20 companies shortlisted from over 500 applicants, and 4 highly competitive finalists, Opharmic has been voted as the Grand Prize winner of the APAC Medtech Innovator Competition 2021, taking home a US$175,000 cash award in addition the valuable winner title endorsed by the global MedTech industry! We are also extremely proud to be the very first Hong Kong company who has won this representative competition throughout the MTI history.
In addition, we are tremendously happy to also bagged the Cambridge Consultants Product Development Prize of US$25,000, and more importantly for the endorsements on our product development and regulatory strategy from one of the globally leading medical device development firm.
Throughout the past 3 months at the largest global Medtech accelerator program, we have gained valuable insights and endorsements from our corporate mentors at Johnson & Johnson, Align Technology, and Cambridge Consultants. We very much look forward to leverage on the network built as we strive toward our goal in bring Opharmic to the next level.
Our Mentors at MTI:
Stay tuned for upcoming press release and featuring events!